QHP Capital-backed Spectra Medical Devices completed the acquisition of XL Precision Technologies from Rubicon Partners.

QHP Capital-backed Spectra Medical Devices, a manufacturer of made-to-spec procedural needle, completed the acquisition of XL Precision Technologies, a CDMO specializing in the manufacture of precision micro-components, complex tubular components, and sub-assemblies for the medical device industry, from Rubicon Partners, a venture capital company. FInancial terms were not disclosed. “We are thrilled to announce Spectra’s acquisition of XL-PT. This acquisition expands and enhances our development and manufacturing capabilities allowing us to do more for our customers and the medical device community,” Chad Nikel, Spectra CEO.